Light Therapy for Obsessive-compulsive Disorder (OCD)
Washington University School of Medicine · NCT06720090
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 17–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- December 16, 2024
- Record last updated
- August 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to test whether light therapy is effective for reducing symptoms in young adults with OCD and late bedtimes (1am or later). The main question[s] it aims to answer are:
Does light therapy reduce OCD symptoms? Does light therapy advance the circadian clock? If there is a comparison group: Researchers will compare a higher dose of light therapy to a lower dose to see if dose amount affects symptom reduction.
Participants will asked to
- Wear light therapy glasses for 1 hour each morning and complete a daily light therapy log for 5 weeks
- Track their sleep every day with a wearable monitor and an electronic sleep diary for 5 weeks
- Complete a 1-time assessment of sensitivity to light exposure
- Complete self-report measures of OCD 4 times/day at baseline (2 weeks), mid-treatment (1 week), and end of treatment (1 week)
Being studied: Light therapy
Conditions: OCD
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Primary DSM-5 OCD diagnosis
- Bedtime 0100 or later
- Age 18-35
- English speaking
Exclusion Criteria
- Subjects must not be currently participating in another research study that would influence their participation in our study.
- Diagnostic status
- Treatment status
- Night shift work or travel more than 1 time zone outside of Central Standard Time (CST) in the past month
- Pregnancy status
- Medication status
- Regular nicotine or marijuana use
Recruiting US locations
Washington University
St Louis, MO 63130
Site contact: Rebecca Cox, PhD · 314-935-8111 · cox.r@wustl.edu
Study contacts (from the official record)
- Rebecca Cox, BA · 314-935-8111 · scraplab@wustl.edu
Similar studies in Missouri
All sleep studies in Missouri →- Recruiting
Evaluation of the F&P Mask, US, 2026
Fisher and Paykel Healthcare
- Location
- St Louis, MO
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Takeda
- Location
- St Louis, MO + 24 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- St Louis, MO + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Alkermes, Inc.
- Location
- St Louis, MO + 21 other US sites
- Eligibility basics
- Ages 18–70